# Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast Cancer

> **NCT01440413** · NA · UNKNOWN · sponsor: **Centre Leon Berard** · enrollment: 40 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** Blood and tumor sample

## Key facts

- **NCT ID:** NCT01440413
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-12
- **Primary completion:** 2018-12
- **Final completion:** 2020-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01440413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01440413, "Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast Cancer". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01440413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*